Product Highlight - Rebamipide (Remasta)
27 Feb 2024
Acid related disease management REMASTERED
•Indicated for the treatment of gastric ulcer.1
•For the improvement of gastric mucosa lesion (erosion, flare and edema) of the following diseases: Acute gastritis, acute aggravated period of chronic gastritis.1
REFERENCE:
1. Full prescribing information of Rebamipide (Remasta) - The Cathay Drug Company, Inc.
THE CATHAY DRUG COMPANY, INC.
2/F Vernida I Condominium, 120 Amorsolo St.,
Legaspi Village, Makati City
Website: www.cathaydrug.ph
•Indicated for the treatment of gastric ulcer.1
•For the improvement of gastric mucosa lesion (erosion, flare and edema) of the following diseases: Acute gastritis, acute aggravated period of chronic gastritis.1
REFERENCE:
1. Full prescribing information of Rebamipide (Remasta) - The Cathay Drug Company, Inc.
THE CATHAY DRUG COMPANY, INC.
2/F Vernida I Condominium, 120 Amorsolo St.,
Legaspi Village, Makati City
Website: www.cathaydrug.ph
